InvestorsHub Logo
Followers 5213
Posts 24106
Boards Moderated 5
Alias Born 09/20/2000

Re: oska t post# 142147

Tuesday, 08/17/2021 7:00:20 PM

Tuesday, August 17, 2021 7:00:20 PM

Post# of 143141
CBYI/iFirst Medical Technologies & NASA Connection...

As indicated, the new CEO of CBYI is Luke Joseph who is also the CEO of iFirst Medical Technologies
https://www.linkedin.com/in/luke-joseph-5512834
https://www.ifirstmedtech.com/

To get an idea of what could be coming into CBYI, I strongly suggest all to listen to the video below from the Hawaii news:


Hawaii start-up recognized by NASA for life-saving medical breakthrough
https://www.hawaiinewsnow.com/story/37130899/hawaii-start-up-recognized-by-nasa-for-life-saving-medical-breakthrough/
(Click on link above to see this particular video.)


Then I suggest all to listen to the presentation from the new CEO of CBYI (Luke Joseph) to fully understand the magnitude of this new medical breakthrough technology to understand why this "Lab on a Device" or "Mobile Lab" made the Top 10 in NASA's iTech Challenge for its list of innovative breakthroughs:


https://sultanventures.com/companies/ifirst-medical-technologies/

iFirst Medical Technologies is revolutionizing health care, by bringing the lab to the patient. Our solution provides a new standard-of-care in coagulation diagnostics. Existing tests such as PT/INR, do not provide the sensitivity or depth of Information needed in critical care applications, such as traumatic Injury or surgical monitoring. In addition, cardiac and stroke patients need a modernized coagulation test, to fulfill the needs of traditional and new anticoagulants. Since our solution is easy to use, mobile and inexpensive, it can be used in conventional applications such as laboratories, as well as expanding into the OR, ER and even ambulances. In ambulances, iFirst’s “mobile lab” enables lifesaving information to be transmitted to the hospital, prior to patient arrival. This allows blood products to be ready upon the patient’s arrival. iFirst envisions the continued growth of products using our mobile health diagnostic platform in the future and we will continue to pursue other critical situations, where ease of use, cost and mobility can help save lives of patients and help care providers increase profits.



v/r
Sterling

Exit Strategy & Etiquette Thoughts for a Stock
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=128822531
I never give investing advice; only my beliefs for risks in a stock.